Drug Shortage Report for MOVIPREP

Last updated on 2022-10-01 History
Report ID 166431
Drug Identification Number 02359499
Brand name MOVIPREP
Common or Proper name Macrogol 3350, Sodium sulphate anhydrous, Sodium chloride, Potassium chloride, Ascorbic acid, Sodium ascorbate
Company Name ARALEZ PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) ASCORBIC ACID SODIUM ASCORBATE POTASSIUM CHLORIDE SODIUM CHLORIDE SODIUM SULFATE ANHYDROUS POLYETHYLENE GLYCOL 3350
Strength(s) 4.7G 5.9G 1.015G 2.691G 7.5G 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration ORAL ORAL
Packaging size cartons containing 2 sachets A and 2 sachets B
ATC code A06AD
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-08-10
Estimated end date
Actual end date 2022-09-30
Shortage status Resolved
Updated date 2022-10-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6733 MISSISSAUGA RD
MISSISSAUGA, ONTARIO
CANADA L5N 6J5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-10-01 English Compare
v9 2022-09-30 French Compare
v8 2022-09-30 English Compare
v7 2022-09-30 French Compare
v6 2022-09-30 English Compare
v5 2022-09-30 French Compare
v4 2022-09-30 English Compare
v3 2022-08-11 English Compare
v2 2022-08-10 French Compare
v1 2022-08-10 English Compare

Showing 1 to 10 of 10